Carlos Bregni | OMICS International
ISSN: 2329-9053

Journal of Molecular Pharmaceutics & Organic Process Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Carlos Bregni

Faculty of Pharmacy and Biochemistry, Junin 956, Buenos Aires

In vitro Inhibition of Leishmania braziliensis Promastigotes Growth by a Fluconazole Microemulsion

Cutaneous leishmaniasis (CL) is the most prevalent form of the disease caused by the parasites Leishmania. However, effective topical treatments for the disease are lacking. Fluconazole (FLZ) is an antifungal agent that inhibits a key enzyme for the production of ergosterol, the main sterol in membranes of fungi and parasites. An in vitro eval... Read More»

Claudia Salerno, Adriana M Carlucci, Susana Gorzalczany and Carlos Bregni

Research Article: J Mol Pharm Org Process Res 2014, 2:115

DOI: 10.4172/2329-9053.1000115

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article